Palmsens
spacer
spacer

The Royal Society of Chemistry is partnering with InnoCentive to provide you with an opportunity to tackle a variety of scientific and non-technical problems.

We recently launched our Open Innovation Pavilion on InnoCentive.com which features InnoCentive-customer Challenges that seek innovative solutions.

Do you have a possible solution to one of the Challenges below?

Anyone can submit solutions, with cash awards on offer for the winning Solvers. Click on the links below to unlock new routes to collaboration and to help address some of the greatest Challenges facing our world today.

Featured Challenges:

spacer

The SUDEP Institute Challenge: Developing Predictive Biomarkers of Epilepsy Seizures

Share this challenge:
Facebook Share Twitter Share

AWARD: $1,000,000 USD
DEADLINE: 10/10/20

Nearly 3 million people in the United States and 65 million people worldwide have epilepsy, a neurological condition which affects the nervous system and causes seizures. Among those living with epilepsy, nearly one-third have ongoing seizures despite existing therapies. Each year, more than 1 out of 1,000 people with epilepsy die from sudden unexpected death in epilepsy (SUDEP). If seizures are uncontrolled, the risk of SUDEP increases to more than 1 out of 150. SUDEP is the leading cause of death in young adults with uncontrolled seizures.

In order to accelerate the identification of effective treatments for SUDEP, the Epilepsy Foundation SUDEP Institute is sponsoring a Reduction to Practice Challenge to develop a predictive biomarker or panel of biomarkers to identify people at risk for SUDEP or seizures that compromise cardiac or respiratory function. The biomarker(s) must serve as an endpoint or surrogate endpoint that will drive human SUDEP interventions. For example, the biomarker(s) may identify a high risk patient group that could be used to test existing candidate interventions such as seizure detection devices.

This is a Reduction to Practice Challenge that requires written documentation, experimental proof-of-concept data, and biomarker validation data.

spacer
spacer

How to Prevent Hydrophobic Anionic Adhesives ("stickies") from Forming Lumps?

Share this challenge:
Facebook Share Twitter Share

AWARD: $20,000 USD
DEADLINE: 9/12/16

Recycled paper fibers from books, magazines, etc., are used to produce carton board. These waste fibers carry with them residues of hydrophobic adhesives − "stickies" − that tend to form lumps that cause disruptions in the board production line and defective goods, both with high economic consequences.

The Seeker is looking for new methods to prevent the formation of such lumps, either by removing the residual stickies or neutralizing their adhesive properties that cause the lumps.

This is a Reduction-to-Practice Challenge that requires submission of written documentation from the Solver. The Seeker will perform experimental validation of proposed solutions in order to determine the award.

spacer
spacer

Emerging Modalities with High Therapeutic Potential to Treat Human Diseases

Share this challenge:
Facebook Share Twitter Share

AWARD: Varies
DEADLINE: 9/25/16

Bringing a new pharmaceutical to market is a long, expensive, and complex process that encompasses research, development, approval, and commercialization. Many promising drug candidates fail in the clinic due to shortcomings in their efficacy, safety, or tolerability. Advances have been made to mitigate these issues and these include the identification of translational biomarkers, improvements in finding and optimization of small molecules or antibodies as established therapeutic modalities, and the use of more predictive models reflecting novel disease concepts. These strategies are effective, yet they might not lead to the next breakthrough therapy. Therefore, Boehringer Ingelheim (the Seeker) is looking one step further to find novel therapeutic modalities that have the potential to modulate targets of human disease including such that are usually not amenable by established modalities. Thus, Boehringer Ingelheim (the Seeker) desires partners to find and develop emerging modalities that have high potential to treat or modulate human disease.

This is an electronic Request-for-Partners (eRFP) Challenge; the Solver will only need to submit a written proposal to be evaluated by Boehringer Ingelheim with the goal of establishing a collaborative partnership

spacer
spacer

Enel Challenge: Replacing a Coagulant for Water Treatment

Share this challenge:
Facebook Share Twitter Share

AWARD: $10,000
DEADLINE: 9/15/16

Aluminum sulfate Al2(SO4)3 is used as a coagulant in a water treatment process to obtain clarified water. The clarified water is further directed to demineralization (for feed boilers). While aluminum sulfate is effective in achieving the desired result, its use is associated with unacceptably high aluminum content in wastewater (> 0.04 mg/dm3 soluble aluminum). The Seeker for this Challenge is looking for an effective coagulant/process to cost-effectively treat the water without the negative side effect of high aluminum content in the effluent water.

This is an Ideation Challenge with a guaranteed award for at least one submitted solution.

spacer
spacer

SUEZ Challenge: Seeking Processes for Profitable Recovery of Sulfates from Wastewater

Share this challenge:
Facebook Share Twitter Share

AWARD: $15,000
DEADLINE: 9/11/16

Current methods to recover sulfates from wastewater streams are limited in their capability to work in challenging industrial conditions and/or to generate a new revenue stream from the recovered sulfates. Hence, SUEZ is looking for a solution to solve these two limitations.

This Theoretical Challenge requires only a written proposal.

spacer

Copyright © 2016 Royal Society of Chemistry, All rights reserved.

Facebook Share Twitter Share Twitter Share

spacer